Contents
Current Medicinal Chemistry, Volume 10 - Number 17
Virus Entry as a Target for Anti-HIV Intervention
, 10(17): 1617 - 1632Jose A. Este
DOI: 10.2174/0929867033457098
Inhibiting HIV-1 Entry with Fusion Inhibitors
, 10(17): 1633 - 1642C. E. Baldwin, R. W. Sanders and B. Berkhout
DOI: 10.2174/0929867033457124
Hologram Quantitative Structure-Activity Relationships Investigations of Non-nucleoside Reverse Transcriptase Inhibitors
, 10(17): 1661 - 1677Pornpan Pungpo, Supa Hannongbua and Peter Wolschann
DOI: 10.2174/0929867033457106
HIV-1 Protease Inhibitors: A Comparative QSAR Analysis
, 10(17): 1679 - 1688Alka Kurup, Suresh B. Mekapati, Rajni Garg and Corwin Hansch
DOI: 10.2174/0929867033457070
Towards the Design and Development of Agents with Broad Spectrum Chemotherapeutic Properties for the Effective Treatment of HIV / AIDS
, 10(17): 1689 - 1695Dharmarajan Sriram and Perumal Yogeeswari
DOI: 10.2174/0929867033457142
Combretastatin A-4 Analogues as Antimitotic Antitumor Agents
, 10(17): 1697 - 1722Nguyen-Hai Nam
DOI: 10.2174/0929867033457151
The Isoprostanes: Unique Products of Arachidonic Acid Oxidation-A Review
, 10(17): 1723 - 1740Samuel S. Fam and Jason D. Morrow
DOI: 10.2174/0929867033457115
Design of β-Lactams with Mechanism Based Nonantibacterial Activities
, 10(17): 1741 - 1757Grigory Veinberg, Maxim Vorona, Irina Shestakova, Iveta Kanepe and Edmunds Lukevics
DOI: 10.2174/0929867033457089
A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase
, 10(17): 1759 - 1764T. Inoguchi, H. Tsubouchi, T. Etoh, M. Kakimoto, T. Sonta, H. Utsumi, H. Sumimoto, H. Y. Yu, N. Sonoda, M. Inuo, N. Sato, N. Sekiguchi, K. Kobayashi and H. Nawata
DOI: 10.2174/0929867033457133
Webmaster Contact: info@benthamscience.net